Ad-AS/hep (Novartis/Tsukuba Research Institute)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameAd-AS/hep (Novartis/Tsukuba Research Institute)
Drug Alias Nameantisense oligonucleotide heparanase inhibitor (Novartis/Tsukuba Research Institute)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionHeparanase inhibitors
TargetsHeparanase
Therapy Area/IndicationsNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Kk
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma KkTsukuba Research Institute
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A